People

Jack Capers, a partner in our Mergers & Acquisitions practice, specializes in U.S. and cross-border corporate transactions. Jack’s practice is focused on technology and life sciences companies. He advises these companies on a broad range of corporate transactions including mergers, acquisitions, dispositions, spin-offs and divestitures, joint ventures, strategic alliances and strategic investments, complex in-licensing and out-licensing transactions, collaboration and development agreements, and commercialization, marketing and supply arrangements.

He also represents clients in the consumer products, retail, industrial and manufacturing, real estate, food and beverage, telecommunications and transportation industries. In addition, Jack advises boards of directors and board committees on corporate governance, M&A transactions and takeover defenses.

A frequent speaker and author, Jack addresses topics in M&A and other corporate matters.

Admitted only in Georgia.
Full Bio

Credentials

J.D., University of Georgia School of Law, Order of the Coif

B.A., Vanderbilt University, magna cum laude

California

Georgia

American Bar Association

Atlanta Bar Association

Best Lawyers In America

California Bar Association

Chambers Ranked

State Bar of Georgia

Life Siences Star in Mergers & Acquisitions


LMG Life Sciences

The Best Lawyers in America


Chambers

America’s Leading Lawyers for Business


Chambers USA

Georgia Super Lawyer


Atlanta Magazine

Icon close

Close

Recognition

Life Siences Star in Mergers & Acquisitions


LMG Life Sciences

The Best Lawyers in America


Chambers

America’s Leading Lawyers for Business


Chambers USA

Georgia Super Lawyer


Atlanta Magazine

Matters

Represented Eisai Pharmaceuticals in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer’s and related commercial arrangements.

Represented Belk Stores, a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion.

Represented Aurrion, a developer of silicon photonics, in the sale of the company to Juniper Networks.

See more
Icon close

Close

Matters

Represented Eisai Pharmaceuticals in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer’s and related commercial arrangements.

Represented Belk Stores, a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion.

Represented Aurrion, a developer of silicon photonics, in the sale of the company to Juniper Networks.

Represented Cognea Pty, a developer of artificial intelligence software and technology, in the sale of the company to IBM.

Represented Arbor Pharmaceuticals, a specialty pharmaceutical company, in a control investment in the company by KKR.

Represented GlaxoSmithKline in the acquisition of Basilea, S.A., a pharmaceutical company in Switzerland, for £200 million.

Represented GlaxoSmithKline in the acquisition of Okairos AG, a developer of vaccines products based in Italy and Switzerland, for US$324 million.

Represented Inmar, a data analytics company, in a joint venture with an international provider of point-of-sale technology to develop a platform for the collection and evaluation of customer purchasing data.

Represented Immucor, a blood diagnostics company, in its US$1.9 million merger with TPG.

Matters

Represented Eisai Pharmaceuticals in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer’s and related commercial arrangements.

Represented Belk Stores, a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion.

Represented Aurrion, a developer of silicon photonics, in the sale of the company to Juniper Networks.

See more
Icon close

Close

Matters

Represented Eisai Pharmaceuticals in a restructuring of its worldwide collaboration with Biogen for the development of products for the treatment of Alzheimer’s and related commercial arrangements.

Represented Belk Stores, a 300-store department store company, in the sale of the company to Sycamore Partners for US$3.1 billion.

Represented Aurrion, a developer of silicon photonics, in the sale of the company to Juniper Networks.

Represented Cognea Pty, a developer of artificial intelligence software and technology, in the sale of the company to IBM.

Represented Arbor Pharmaceuticals, a specialty pharmaceutical company, in a control investment in the company by KKR.

Represented GlaxoSmithKline in the acquisition of Basilea, S.A., a pharmaceutical company in Switzerland, for £200 million.

Represented GlaxoSmithKline in the acquisition of Okairos AG, a developer of vaccines products based in Italy and Switzerland, for US$324 million.

Represented Inmar, a data analytics company, in a joint venture with an international provider of point-of-sale technology to develop a platform for the collection and evaluation of customer purchasing data.

Represented Immucor, a blood diagnostics company, in its US$1.9 million merger with TPG.

Credentials

J.D., University of Georgia School of Law, Order of the Coif

B.A., Vanderbilt University, magna cum laude

California

Georgia

American Bar Association

Atlanta Bar Association

Best Lawyers In America

California Bar Association

Chambers Ranked

State Bar of Georgia

Life Siences Star in Mergers & Acquisitions


LMG Life Sciences

The Best Lawyers in America


Chambers

America’s Leading Lawyers for Business


Chambers USA

Georgia Super Lawyer


Atlanta Magazine

Icon close

Close

Recognition

Life Siences Star in Mergers & Acquisitions


LMG Life Sciences

The Best Lawyers in America


Chambers

America’s Leading Lawyers for Business


Chambers USA

Georgia Super Lawyer


Atlanta Magazine